← All organizations
Highest phase reached
Phase 2
First clinical trial
Feb 1, 2010Last known activity
Dec 30, 2025
Defunct as of Mar 15, 2022
Timeline
2000s
- Jun 1, 2007
Juventas Therapeutics, Inc.— Founded
- Apr 1, 2009
AcelRx Pharmaceuticals, Inc.— Acquired
2020s
- Mar 15, 2022
Juventas Therapeutics, Inc.— Defunct
Drugs by trial phase (20 distinct, 42 trials)
Phase 3 (0 own, 2 via acquisition)
Phase 2 (11 own, 1 via acquisition)
Phase 1 (4 own, 1 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (25)
- NCT04008524CollaboratorN/A—
- NCT07265206Lead sponsorEarly Phase 1Dec 30, 2025
- NCT07091370Lead sponsorPhase 1Dec 27, 2025
- NCT07275736Lead sponsorEarly Phase 1Dec 15, 2025
- NCT06826430Lead sponsorPhase 1Mar 1, 2025
- NCT06676982CollaboratorPhase 1Dec 1, 2024
- NCT06608732CollaboratorPhase 2Aug 1, 2024
- NCT06608342CollaboratorPhase 2Jun 25, 2024
- NCT06231368CollaboratorPhase 1Feb 4, 2024
- NCT06005649Lead sponsorPhase 1/Phase 2Oct 31, 2023
- NCT06009107Lead sponsorPhase 1/Phase 2Oct 18, 2023
- NCT05667506Lead sponsorPhase 1/Phase 2Jan 6, 2023
- NCT06316791Lead sponsorEarly Phase 1Dec 14, 2021
- NCT04690192CollaboratorPhase 1/Phase 2Jan 1, 2021
- NCT04684147Lead sponsorPhase 2Dec 31, 2020
Details
- Founded
- Cleveland, OH, US Jun 1, 2007
- Last known activity
- Dec 30, 2025